AB
MCRB icon

Amalgamated Bank’s Seres Therapeutics MCRB Stock Holding History

Amalgamated Bank’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-120
Closed -$2K – 3072
2024
Q1 		$2K Sell
120
-436
-78% -$9.4K ﹤0.01% 2893
2023
Q4 		$16K Sell
556
-36
-6% -$945 ﹤0.01% 2746
2023
Q3 		$28K Hold
592
– – ﹤0.01% 2495
2023
Q2 		$57K Buy
592
+104
+21% +$11.3K ﹤0.01% 2264
2023
Q1 		$55K Sell
488
-74
-13% -$8.01K ﹤0.01% 2271
2022
Q4 		$63K Hold
562
– – ﹤0.01% 2325
2022
Q3 		$72K Buy
562
+9
+2% +$922 ﹤0.01% 2303
2022
Q2 		$38K Sell
553
-14
-2% -$1.21K ﹤0.01% 2611
2022
Q1 		$81K Sell
567
-47
-8% -$7.23K ﹤0.01% 2281
2021
Q4 		$102K Sell
614
-17
-3% -$2.7K ﹤0.01% 2062
2021
Q3 		$88K Sell
631
-26
-4% -$5.09K ﹤0.01% 2093
2021
Q2 		$313K Buy
+657
New +$277K ﹤0.01% 1861
2021
Q1 		– Sell
-431
Closed -$211K – 1614
2020
Q4 		$211K Buy
431
+18
+4% +$10.5K 0.01% 1424
2020
Q3 		$234K Buy
+413
New +$137K 0.01% 1244

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Amalgamated Bank's MCRB Position: Q2 2024 in Review

Amalgamated Bank sold out of Seres Therapeutics (MCRB) in Q2 2024, closing a stake of 120 shares — an estimated $2K sold.

Amalgamated Bank first reported a position in MCRB in Q3 2020 and held it in 14 quarters. The position peaked at $313K in Q2 2021. 93 funds tracked by Wall St. Rank hold MCRB as of Q2 2024.

  • Amalgamated Bank reported no remaining Seres Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Amalgamated Bank sold 120 Seres Therapeutics shares in Q2 2024, an estimated $2K.
  • Amalgamated Bank first reported a position in Seres Therapeutics in Q3 2020 and held it in 14 quarters.
  • Amalgamated Bank's Seres Therapeutics position peaked at $313K in Q2 2021.
  • 93 funds tracked by Wall St. Rank held Seres Therapeutics as of Q2 2024.

Based on Amalgamated Bank's 13F filing for Q2 2024, filed 12 Aug 2024.